Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma
Background: Multiple myeloma (MM) is a type of blood cancer that affects a person s immunity. MM returns after treatment (relapse) in almost all people; MM may also not r…
Cellular📎 ClinicalTrials.gov · 2026-09-04 링크 Everolimus Aging Study
The objective of this project is to determine if mTORC1 inhibition by 24 weeks of daily (0.5 mg/day) or weekly (5 mg/week) everolimus can safely improve physiological and…
Rapamycin📎 ClinicalTrials.gov · 2026-09-04 링크 Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized T…
Background: As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and levels of blood glucose (sugar) rise. This can lead t…
Cellular📎 ClinicalTrials.gov · 2026-09-04 링크 Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumula…
Both controlled ovarian stimulation (COS) and frozen embryo transfer has become an integral part of in vitro fertilization (IVF) treatment. Fresh embryo transfer is usual…
Senolytic📎 ClinicalTrials.gov · 2026-09-04 링크 RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
This is a phase I, randomized, double-blind, placebo-controlled clinical trial to investigate the safety of VRC07-523LS and PGDM1400LS in combination with ChAdOx1.tHIVcon…
Cellular📎 ClinicalTrials.gov · 2026-09-04 링크 Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
The study will measure the safety, tolerability, and efficacy with acalabrutinib in combination with rituximab in treatment-naïve elderly and/or frail patients with diffu…
Cellular📎 ClinicalTrials.gov · 2026-09-04 링크